About Boehringer Ingelheim China
Boehringer Ingelheim entered into the Chinese market in 1994, headquartered in Shanghai with more than 3000 employees. The major business focuses of BI China include prescription medicine, consumer health care, animal health and biopharmaceuticals. In recent years, BI has achieved continuous growth, outperformed the market average. BI has been certified as “China Top Employer” during 2014 to 2016. To become the premier multinational pharmaceutical company is the vision of Boehringer Ingelheim China. The company aims to bring more and better innovative products earlier to patients to enhance their health and life quality.
Facts & Figures
|Number of employees||3500|
|Number of active countries||145|